DuPont Pioneer, Broad Institute maximize access to CRISPR-Cas9

WASHINGTON, Oct. 25, 2017 - Two organizations that control the licensing of much of the foundational CRISPR-Cas9 genome editing intellectual property for use in agriculture decided to work together to make these tools available non-exclusively, removing roadblocks to expanded use of this technology.